Health Boards
›
Psoriasis In The News
Lycera initiates phase2 trial of LYC-30937-EC for psoriasis
|
Lycera initiates phase2 trial of LYC-30937-EC for psoriasis
|
Thu-08-12-2016, 13:10 PM
(Wed-07-12-2016, 18:52 PM)jiml Wrote: It's good to see that Lycera are looking at the disease from a different angle, I hope that this oral drug will be successful as it will give dermatologists another weapon in their arsenal to attack this disease Yes, seemingly it searches for the/certain lymphocytes as the carriers. |
|
« Next Oldest | Next Newest »
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
IMG-004 starts phase I clinical trial | Fred | 2 | 2,073 |
Tue-17-05-2022, 06:48 AM Last Post: Caroline |
|
|
Otezla phase 3 advance trial results | Fred | 0 | 1,617 |
Sat-24-04-2021, 11:30 AM Last Post: Fred |
|
|
Idera announce phase 2 trial of IMO-3100 | Fred | 3 | 5,274 |
Sat-20-03-2021, 11:29 AM Last Post: Fred |
|
|
Affibody shows data from Phase 2 trial of ABY-035 for psoriasis | Fred | 6 | 6,296 |
Fri-26-06-2020, 13:31 PM Last Post: Caroline |
|
|
Ilumya / Ilumetri efficacy using phase 2b/3 trial data. | Fred | 0 | 1,685 |
Fri-10-01-2020, 21:25 PM Last Post: Fred |
